New Delhi, Aug. 6 -- Divi's Laboratories Ltd, India's second-largest pharmaceutical company by market capitalization, is expected to report a 14-18% jump in revenue and robust margin expansion for the... Read More
Mumbai, Aug. 6 -- Contract development and manufacturing organization (CDMO) Divi's Laboratories Ltd's June-quarter earnings missed estimates due to pricing pressure on its generics business. While t... Read More
New Delhi, Aug. 5 -- Eris Lifesciences is gearing up to take advantage of India's booming diabetes-obesity market. The Ahmedabad-based drugmaker stands to gain in the country's human insulin market as... Read More